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Gate control theory posits the idea that the brain and spinal cord have the ability to control the 
perception of pain sensation throughout the body. Biofeedback provides a proven way to teach a 
person how they may control their heart rate, breathing, and skin temperature. Through this 
process, individuals learn to lessen their migraine frequency and intensity. There are no studies 
to date that have measured the effectiveness of biofeedback in conjunction with medication for 
migraines in children despite established evidence of success in adults. In this study, an online 
format via SurveyMonkey was used to document the perceptions of parents with regard to the 
observation of their children’s migraines. Pre- and posttreatment measures were recorded to 
document migraine activity with implementation of biofeedback or medication using the 
Individualized Numeric Rating Scale. A total of 48 participants reported about their children’s 
migraine frequency and intensity. One group of 24 parents were asked to give information on 
medication only treatment, and an additional 24 parents provided information on biofeedback 
and medication. The data were processed using 2 mixed model (i.e., 1 within and 1 between) 
ANCOVAs. Although frequency and intensity of migraines decreased across both groups 
posttreatment, there was no statistically significant interaction between the within subject factors 
of time and type. In this particular data set, medication plus biofeedback was not more effective 
than medication alone. The implications for positive social change using the results of this study 
are the potential for happier, healthier, migraine free children who are more able to be productive 
and contribute positively to society.  
 
 
Parent Perceptions of Biofeedback Treatment Effectiveness for Pediatric Migraine 
by 
Andrea Grando Weber 
 
Ed.S., Marshall University, 1999 
MA, Marshall University, 1998 
B.A, West Virginia University, 1990 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 







I would like to dedicate this dissertation to my daughter, Olivia. She has shown great 
strength to persevere through the adversity of chronic migraine in adolescence. Her struggle has 
given me insight into what courage it takes to live with an invisible illness. My hope is that the 
work I have done here will benefit children like Olivia and their families. 
Acknowledgments 
I would like to acknowledge my dissertation committee, Dr. Brandon Cosley, Dr. Jay 
Greiner, and Dr. Peggy Gallaher, for their dedication in helping me complete my dissertation. I 
would also like to thank my husband, Rob, and children, William, Sarah, and Olivia, for acting 
as my personal cheering squad as I have moved through each stage of the dissertation process. 
Thank you for your belief in me and in my ability to make a meaningful contribution to this body 




Table of Contents 
List of Tables .......................................................................................................................v 
Chapter 1: Introduction to the Study ....................................................................................1 
Introduction ....................................................................................................................1 
Background ....................................................................................................................1 
Problem Statement .........................................................................................................3 
Purpose of the Study ......................................................................................................5 
Research Questions and Hypotheses .............................................................................6 
Theoretical Framework for the Study ............................................................................7 
Nature of the Study ........................................................................................................8 
Definitions......................................................................................................................8 
Assumptions ...................................................................................................................9 




Chapter 2: Literature Review .............................................................................................15 
Introduction ..................................................................................................................15 
Literature Search Strategy............................................................................................16 
Theoretical Foundation ................................................................................................16 
Literature Review Related to Key Concepts ................................................................19 
 
ii 
Children’s Migraines: Symptomatology and Prevalence ..................................... 19 
Social and Academic Aspects of Pediatric Migraines .......................................... 21 
Diagnoses of Migraines in Children ..................................................................... 22 
Parent Role in Pain Control for Children with Migraines .................................... 24 
Pharmaceutical Treatments for Children with Migraines ..................................... 25 
CAM Therapies ..................................................................................................... 27 
Case for CAM to Complement Pharmaceutical Therapies ................................... 28 
Role of Pain and Biofeedback in Treating Pediatric Migraine ............................. 29 
Influence of Demographics on Migraines and Biofeedback................................. 30 
Summary and Conclusions ..........................................................................................31 
Chapter 3: Research Method ..............................................................................................32 
Introduction ..................................................................................................................32 
Research Design and Rationale ...................................................................................32 
Methodology ................................................................................................................34 
Population ............................................................................................................. 34 
Sample and Sampling Procedures ......................................................................... 34 
Procedures for Recruitment, Participation, and Data Collection .......................... 35 
Instruments and Operationalization of Constructs ................................................ 37 
Data Analysis Plan ................................................................................................ 40 
Threats to Validity .......................................................................................................42 




Chapter 4: Results ..............................................................................................................45 
Introduction ..................................................................................................................45 
Data Collection ............................................................................................................46 
Data Management ................................................................................................. 47 
Descriptive Statistics ............................................................................................. 47 
Results 49 
Research Subquestion 1 ........................................................................................ 52 
Research Subquestion 2 ........................................................................................ 54 
Summary ......................................................................................................................56 
Chapter 5: Discussion, Conclusions, and Recommendations ............................................57 
Introduction ..................................................................................................................57 
Interpretation of Findings ............................................................................................58 
Omnibus Research Question ................................................................................. 58 
Frequency of Migraines ........................................................................................ 59 
Intensity of Migraines ........................................................................................... 60 
Theoretical Framework ......................................................................................... 60 







Appendix A: Demographic Survey ....................................................................................77 




List of Tables 
Table 1. Frequency Table for Categorical Variables ........................................................ 48 
Table 2. Summary Statistics for Parent and Child Age .................................................... 49 
Table 3. Results of KS Tests ............................................................................................. 51 
Table 4. Results of Mixed Model ANCOVA Involving Frequency of Migraines ........... 53 
Table 5. Means and Standard Deviations for Factor Level Combinations Involving 
Migraine Frequency .................................................................................................. 53 
Table 6. Results of Mixed Model ANCOVA Involving Intensity of Migraines .............. 55 




Chapter 1: Introduction to the Study  
Introduction 
Migraine is the sixth most disabling illness in the world (Migraine Research 
Foundation [MRF], 2019). Children of school age show a 10% incidence rate of migraine 
diagnosis (MRF, 2019). Identifying techniques that reduce the symptoms and frequency 
of migraines in children could bring about significant positive social change through the 
increased productivity and participation for those children afflicted with this disabling 
condition. In this study, I compared parent observation and complimentary integrated 
medicine (CIM) in the form of biofeedback to medication treatment alone to determine if 
use of CIM improves the rate and intensity of migraine occurrence.  
Background 
Migraine headaches in children begin before the age of 5 for one quarter of 
migraine sufferers and begin before the age of 20 in more than half of child migraine 
sufferers (National Headache Foundation, 2007). More than 20% of migraine sufferers 
are considered to be disabled; this number increases with accompanying comorbid 
conditions (MRF, 2017). Complementary and alternative medicines (CAM) for migraines 
have proven effective within adult populations. For example, nondrug therapies, such as 
chiropractic (Tuchin, 1997) and biofeedback and acupuncture (Millstine, Chen, & Bauer, 
2017), have proven effective in treating adult migraines. The National Headache 
Foundation endorses biofeedback, acupuncture, and cognitive behavioral therapy (CBT) 
as alternative migraine therapies for adults (Guirguis-Blake, 2010). Of the alternative 
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therapies, biofeedback is one of the more effective behavioral approaches and lends itself 
to use as an alternative or complementary treatment (Nestoriuc & Martin, 2007). 
Biofeedback helps patients learn to control their personal physiology through the 
reporting of continuous feedback of their biological response (Nestoriuc & Martin, 2007).  
Researchers have found biofeedback to be more effective than acupuncture and CBT in 
adult populations (Goslin, Gray, & McCrory, 1999). Because children are physiologically 
different than adults, using adult research for children is unreliable; therefore, data 
specifically regarding children is necessary (Jindal, Ge, & Mansky, 2008). 
The CAM treatments may be helpful among children because treating migraines 
with drug therapies in children has been problematic for researchers. Papetti et al. (2010) 
established that pharmaceutical treatment of migraines in children have many negative 
side effects. General studies of alternative pain relief methods in children, such as 
acupuncture (Jindal et al., 2008) and distraction (He, Polkki, Pietila, & Vehvilaien-
Julkunen, 2006), showed success in the emergency room, postsurgical settings, and 
abating aftereffects of chemotherapy treatments. Furthermore, researchers have shown 
positive results for pediatric migraines from nondrug therapies, such as diet (Eidlitz-
Markus, Haimi-Cohen, Steier, & Zeharia, 2009); CBT (Powers et al., 2013); biofeedback 
(Herman & Blanchard, 2002); and acupuncture (Jindal et al., 2008). However, compared 
to pharmaceutical interventions, research on CAM therapies among children in 
conjunction with pharmaceutical treatments have been relatively sparse, especially 
among the very young (Eidlitz-Markus et al., 2010).  
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In part, the lack of research may have resulted from ethical issues and from the 
view that children are difficult study subjects. Children may manifest pain differently 
than adults, necessitating a different process of evaluation (Jindal et al., 2008). One 
method of gaining reliable feedback is to use caregiver responses as a method of 
understanding the child’s response to feedback (Vetter, Bridgewater, & McGwinn, 2012). 
Studies that focused on general pain relief in children have frequently included parent 
and caregiver evaluations (He et al., 2006). Additionally, researchers found caregivers 
may be better able to assess pain in their children than health care professionals (Craig, 
Lily, & Gilbert, 1996; Jylli & Olsson, 1995).   
Biofeedback has also been shown to be effective in treating migraine symptoms 
for children (Eccleston, Morley, Williams, Yorke, & Mastroyannopoulou, 2001; 
Hermann & Blanchard, 2002; Jindal et al., 2008; Levy et al., 2010; Powers et al., 2013). 
However, no researchers have measured the comparative effectiveness of biofeedback as 
a complementary treatment method in child migraine patients using parent and caregiver 
assessments. Through this study, I addressed this gap in the literature to gain increased 
understanding of the use of biofeedback in conjunction with pharmaceutical treatment 
through the parent and caregiver assessments. 
Problem Statement 
According to the U.S. Department of Health and Human Services, 29.5 million 
Americans are affected by migraines (Doheny, 2013). Worldwide, 60% of children suffer 
from headaches of varying intensity and length (Abu-Arafeh, Razak, Silvaraman, & 
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Graham, 2010). Researchers have proven nonpharmacological CAM therapies, such as 
acupuncture and chiropractic, effective in the treatment of migraine illness for adults 
(Molsberger, 2012; Tuchin, 1997); however, children are physiologically different from 
adults. As a result, research data obtained from adult studies cannot be extrapolated to 
children (Jindal et al., 2008). Biofeedback, acupuncture, and CBT therapies have shown 
promise for effective pain reduction in child migraine pain (Eccleston et al., 2001; 
Hermann & Blanchard, 2002; Jindal et al., 2008).  
No studies have measured the effectiveness of medication and biofeedback in 
child migraine patients, but among adults, biofeedback affords significant symptom 
improvement more than acupuncture (Goslin et al., 1999). In my review, I could locate 
no extant literature measuring the effectiveness of biofeedback as a complementary 
treatment for pediatric migraine as measured by parent and caregivers. Through this 
study, I intended to develop data to determine whether biofeedback as a complementary 
therapy provides effective symptom improvement in child migraine patients. I measured 
therapeutic effectiveness by compiling parental perceptions of child migraine responses, 
thereby demonstrating which and to what extent complementary biofeedback treatment 
results in fewer migraine episodes during a 1-month period.  
 I focused on all children under the age of 18 years old who had been previously 
diagnosed with migraine headaches. Parents and caregivers may be better able to assess 
pain in children than health professionals, and studies in hospital settings have shown that 
pediatric pain relief can be managed better when health care providers consider parent 
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and caregiver ratings (Craig et al., 1996; Jylli & Olsson, 1995). Likewise, researchers 
who incorporated parent input into child migraine treatment response have shown parents 
are able to judge children’s pain levels better than medical staff (Jylli & Oslon, 1995). 
However, scant literature exists specifically on child migraine that involves parent and 
caregiver evaluations (Eidlitz-Markus et al., 2010).  
Through this study, I sought to further explore how parent perceptions of child 
migraine pain may be examined and used to further research. Incorporating parent 
responses into evaluating effectiveness of migraine treatment lends an additional level of 
feedback regarding the effectiveness of treatment beyond doctor and child migraine 
patient feedback. Statistically, parent and child ratings are similar, and adding parent 
input strengthens support for treatment validity (Vetter et al., 2012). It is not known 
whether and how incorporating biofeedback with pharmaceutical treatment among 
children with migraines can reduce migraine-related pain according to parent and 
caregiver responses. 
Purpose of the Study 
 Biofeedback is a recognized alternative migraine therapy for adults (Guirguis-
Blake, 2010) that also shows promise for use in children (Eccleston et al., 2001; 
Hermann & Blanchard, 2002; Jindal et al., 2008). However, no prior researchers have 
measured the effectiveness of this therapy in children by using caregiver assessments to 
more accurately assess the child’s pain level. Research focusing on perceptions of 
medical staff has shown their assessments are not always an accurate assessment of child 
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pain experience (Craig et al., 1996; Jylli & Olsson, 1995). The purpose of this 
quantitative, quasi-experimental study was to measure the effectiveness of biofeedback as 
a complementary therapy in child migraine patients through surveys completed by 
caregivers. The two self-selected groups consisted of parents or caregivers of children 
diagnosed with migraine up to the age of 18 years old and who had treated their 
migraines with medication only or medication in conjunction with biofeedback. 
Caregiver reports documented child migraine patient responses during a 1-month period. 
I intended to identify an effective complementary migraine treatment for children as 
reported by caregivers, thereby addressing the gap in the existing literature.   
Research Questions and Hypotheses 
Omnibus Research Question: Is biofeedback in addition to medication treatment 
more effective in the treatment of child migraines than medication alone? 
H0: Biofeedback in addition to medication is not more effective in the 
treatment of child migraines than medication alone. 
Ha: Biofeedback in addition to medication is more effective in the 
treatment of child migraines than medication alone. 
Research Subquestion 1: Does biofeedback in addition to medication treatment 
reduce the frequency of reported child migraines when compared to medication 
alone? 
H01: Biofeedback in addition to medication does not reduce the frequency 
of reported child migraines when compared to medication alone. 
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Ha1: Biofeedback in addition to medication does reduce the frequency of 
reported child migraines when compared to medication alone. 
Research Subquestion 2: Does biofeedback in addition to medication treatment 
reduce the intensity of reported child migraines when compared to medication 
alone? 
H02: Biofeedback in addition to medication does not reduce the intensity 
of reported child migraines when compared to medication alone. 
Ha2: Biofeedback in addition to medication does reduce the intensity of 
reported child migraines when compared to medication alone. 
Theoretical Framework for the Study 
Melzack and Wall (1965) founded gate control theory, which is a theory of pain. 
Gate control theorists hold that a person’s perception of pain is influenced by her or his 
mood, previous pain experiences, and current emotional state (Wlassoff, 2014). Before 
gate control theory emerged, researchers believed that pain was only influenced by the 
intensity of the pain or extent of physical damage to the body (Wlassoff, 2014).   
According to gate control theory, pain signals do not immediately reach the brain 
following the stimulus (Melzack and Wall, 1965). Signals for pain must pass through 
neurological gates in the spinal cord, and these gates within the spinal cord choose 
whether the pain signals will reach the brain (Melzack and Wall, 1965). When the gate 
“trips” and opens, the brain perceives pain, but when the gate remains closed, the brain 
perceives little or no pain (Mammis, 2015; McCaffrey, Frock, & Garguilo, 2003). This 
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theory supports the idea that an individual’s perception of his or her state of being 
influences his or her perception of pain (Marchant, 2016; McCaffrey et al., 2003). 
Therefore, gate control theorists use the mind-body connection through biofeedback to 
improve a patient’s susceptibility to pain (McCaffrey et al., 2003). I developed the 
hypotheses in this study as tests of gate control theory, in that the theory suggests 
biofeedback may help migraine patients by giving a personal sense of control regarding 
their illness, and in turn, this process will promote healing in the body (see McCaffrey et 
al., 2003). 
Nature of the Study 
The nature of this study was quantitative because I measured reduced migraine 
frequency and perceptions of severity of pain using the Individualized Numeric Rating 
Scale (INRS). I employed a survey completed by primary caregivers of child migraine 
sufferers. Because conducting a randomized controlled trial was not feasible given 
limitations in the study population, I employed a quasi-experimental study design using 
self-selected groups of participants who were treating their children with medication 
alone or medication plus biofeedback treatment. To address any possible demographic 
confounders, demographic covariates, such as child’s age, family income, and gender, 
were included in the study. 
Definitions 
Biofeedback: Electrical sensors connected to an individual that output information 
on bodily functions (Barnett & Shale, 2013). The awareness of this output helps subjects 
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learn to recognize and eventually regulate their responses to stimuli, thereby improving 
their health. The most popular types are electromyography, which gives information on 
muscle tension, and thermal, which measures skin temperature and heart-rate variability 
(Barnett & Shale, 2013). Biofeedback was the independent variable in the study.   
Complimentary alternative medicine (CAM): An alternative medical procedure, 
such as biofeedback, acupuncture, or hypnosis, used to compliment traditional medical 
practices, such as medication to address illness (Barnett & Shale, 2013).  
 Migraine: A neurologically complicated cascade of symptoms consisting of head 
pain, nausea, vomiting, dizziness, photophobia, phonophobia, sensitivity to odors, 
abdominal pain, and mood changes (Pezzuto, 2014). The frequency, duration, and 
intensity of migraines were the dependent variables in this study. 
Parent: Parents or caregivers within the body of the study; a person who brings up 
or cares for another (see Parent, n.d.). 
Assumptions 
One of the basic assumptions made in this study that I believed to be true, 
although not proven, was the honest reporting of information by the participants. A 
researcher must assume that participants will give accurate accounts of what they have 
experienced, such as with respect to the children’s migraine treatment outcomes in this 
study. As previously discussed, I assumed based on previous studies (e.g., Craig et al., 
1996) that caregivers may provide accurate data regarding the pain outcomes of 
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treatments among children who suffer from pain. I also assumed the participants’ 
responses were truthful and accurate to protect the integrity of the study. 
Scope and Delimitations 
Through conducting this research study, I sought to determine whether the use of 
biofeedback in the treatment of child migraine affects a noticeable reduction of migraine 
episodes in the posttreatment period as perceived by the parent or caregiver rater. This 
focus was appropriate because prior researchers have proven parents are the more 
accurate raters of child pain behavior (see Craig et al., 1996). The boundaries of the study 
were the age of the children rated by parents. The ages of the children rated ranged from 
infant to 18 years old. Children had to have been formally diagnosed as having migraine 
illness to be included in the study. Those older than 18 years of age were considered 
adults for the purposes of this study and were excluded.  
The participants in the study were the caregivers of the aforementioned children. 
There was no age restriction for the parent raters. Using parent raters was preferable to 
working directly with the children because of Institutional Review Board (IRB) 
considerations. The view that parents are the best articulators of their children’s pain 
behaviors is clearly reflected in the literature (e.g., Craig et al., 1996). Because some 
children may not be old enough to speak or may not feel comfortable communicating, the 
use of parent input was the best course of action.  
Additional complimentary treatments for migraine considered for the study were 
acupuncture, CBT, and chiropractic interventions. The results may not generalize to adult 
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sufferers of migraines regarding the efficacy of biofeedback in conjunction with 
pharmaceutical therapies. Although the study occurred through an online format, which 
may have conceivably attracted participants from any location, the text of the survey was 
in English and, therefore, limited to English reading individuals.  
Limitations 
A primary limitation of this study was that it was not a randomized trial. 
Randomized trials reduce both researcher and participant bias (Levin, 2007). However, 
given that the subjects were pediatric migraine sufferers and members of a vulnerable 
population, it was difficult to justify intervention as a researcher, particularly for CIM, 
with no evidentiary basis for doing so. Although prior researchers have examined 
biofeedback among adults and shown it as an efficacious treatment less evidence exists 
pertaining to children. A limitation of the quasi-experimental design is that it reduce 
randomness and may have introduced confounding factors, but the body of current 
evidence does not support the use of intervention with this vulnerable population. The 
results of this study lay groundwork for future studies in establishing an understanding of 
caregivers’ perceptions of the efficacy of biofeedback among children with migraines.  
One of the potential design weaknesses was relying on parent input instead of 
child input; however, as previously discussed in this chapter, for children suffering from 
pain, caregivers are accurate at describing their children’s level of pain, especially when 
compared to medical staff’s ratings (Craig et al., 1996). One of the methodological 
weaknesses may have been obtaining the correct number of participants necessary to 
12 
 
carry out specific statistical tests. To address this problem, I contacted various migraine 
support groups for additional participants.  
Additional limitations may have stemmed from researcher bias. I am a parent of a 
child migraine sufferer, which may have lead to some bias. I addressed this by having 
participants self-administer their own surveys through SurveyMonkey. I did not directly 
interact with participants and, therefore, could not influence them or the resulting data.  
A final limitation to the generalizability of the study was the limited amount of 
biofeedback practitioners. Use of biofeedback therapies do not come with the side effects 
that many medications do (Schetzek et al., 2013). If the study demonstrated that 
biofeedback was effective as a CAM therapy for pediatric migraine, the limitation that 
biofeedback is widely unavailable to those suffering from pediatric migraines could have 
posed a problem.  
Significance 
Although researchers have studied alternative therapies for migraine patients 
generally and analyzed pain management techniques for children to evaluate caregiver 
assessments, no researchers have attempted to record caregiver assessments of child 
migraine response to biofeedback as a complimentary therapy. Through the lens of the 
parent’s perception, I examined the effectiveness of biofeedback on child migraine pain 
symptoms. The findings of this study contribute to filling the gap in the literature through 
evaluation of the efficacy of biofeedback as a complementary child migraine therapy 
determined through results obtained from caregiver surveys.   
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Accordingly, researchers who evaluate alternative therapy methods for pediatric 
migraine using parent and caregiver evaluations may provide important data to aid in the 
improvement of treatment methods. The intent of the study was to support all providers 
of migraine therapy for children (i.e., both medical professionals and caregivers) by 
providing concrete data that reflects the efficacy of biofeedback as a complementary 
treatment for migraine in children. The relevance of the study to society is to expand and 
improve the treatment of child migraine through complementary therapy.  
Social change can be brought about through the increased productivity seen with 
optimum health. Helping children to live pain-free lives puts them in a much better place 
to achieve goals and accomplish a higher purpose. In finding the best complementary 
medical treatments to reduce the frequency of migraine pain in children, the results of 
this study contribute to social change by helping to reduce pain in child migraine 
sufferers.  
Summary 
In this chapter, I established the need for additional research in the area of CAM 
for the treatment of child migraine. The use of techniques like biofeedback lessen the 
amount of medication needed, frequency of occurrence, and duration of migraine 
episodes for adults (Nestoriuc, Martin, Reif, & Andrasik, 2008). Because children are 
more susceptible to medication effects, it is highly likely that children will benefit from 
CAM therapy, although no existing studies compare children’s reaction to biofeedback 
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and medication with medication only. The need for this study was apparent via this gap in 
the literature, as I will further discuss in Chapter 2.   
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Chapter 2: Literature Review 
Introduction 
A large population of children suffer from migraine illness: As of the age of 17, 
8% of boys and 23% of girls have experienced a migraine (MRF, 2011). Medication 
options to treat migraine illness with pharmaceuticals can have negative side-effects 
(Papetti et al., 2010). Behavioral sociophysiological options, such as biofeedback, may 
offer relief for many children who suffer from migraine in conjunction with 
pharmaceutical treatments (Hermann & Blanchard, 2002). However, the effectiveness of 
combining biofeedback with pharmaceutical treatment among children with migraines is 
not known. Therefore, the purpose of this quantitative study was to measure the 
effectiveness of biofeedback as a complementary therapy in child migraine patients, as 
shown through surveys completed by caregivers.   
In this chapter, I will discuss (a) the identification of migraine illness in the 
pediatric population; (b) human perception of pain, as explained through gate control 
theory; (c) how biofeedback employs gate control theory techniques to control pain; (d) 
the mechanism of biofeedback itself to treat specifically migraine; and (e) the role of the 
parent or caregiver as observer of symptom improvement in pediatric migraine 
frequency. I undertook a comprehensive literature search to provide information on 
biofeedback, pediatric migraine, chronic migraine, gate control theory, 
nonpharmacological approaches to migraine, and parent perceptions of pain relief in 
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pediatric migraine. This chapter will also include an explanation of the need for this study 
and supporting literature. 
Literature Search Strategy 
The databases I searched were Google Scholar, Walden University Health 
Sciences, and Psychology Databases. Within these databases, I used PubMed and 
PsychInfo most extensively. Search terms included biofeedback, pediatric migraine, 
migraine, migraine non-pharmaceutical interventions, and behavioral interventions for 
pediatric migraine. The literature I reviewed ranged in publication date from 1965 to 
2017. The older articles reflect key contributions to the field and were necessary to 
establish background in the subject matter. The majority of articles referenced for this 
work were from peer-reviewed journals; only 8.6% (5 out of 58) articles were from non-
peer-reviewed publications.       
Theoretical Foundation 
Gate control theory provides a framework for pain control, which helps to explain 
how biofeedback works to lessen the pain of those who have migraines. Melzack and 
Wall (1965) first postulated the theory that pain transmissions may be influenced by the 
thoughts and emotional state of the individual, contrary to the prior conception of pain as 
a purely sensory phenomenon linked to physical circumstances. Previous to the use of 
gate control theory to explain pain, the 17th century philosopher Descartes’s theoretical 
views of specificity were the theory most widely considered. Descartes contended that 
people, although possessing of a soul, were essentially machines with specific pain fibers 
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and pathways and a center of pain within the brain (Melzack and Wall (1965). This 
ultimately resulted in the concept of pain as a linear sensory projection mechanism 
(Melzack, 1993). As late as the 1950s, if a person presented with pain and no physical 
cause was determined, health care providers summarily referred them to the psychiatrist 
(Melzack and Wall (1965). The psychological contributions to pain, such as situational 
meaning, attention, and past experience, were not recognized at this time (Melzack and 
Wall (1965).  
The next attempt at a new pain theory was pattern theory, the precursor to modern 
gate control theory: Goldschieder’s theory proposed that central summation in the dorsal 
horns is one of the vital aspects of pain (Melzack & Wall, 1965).  Noordenbos theory 
(Melzack, 1993) believed that large diameter fibers inhibited smaller diameter fibers and 
that substantia gelitinosa found in the dorsal horns played an important place in 
summation and other processes posited by Livingston. All of these theorists saw the brain 
as a passive end point to which messages were sent. Emphasis eventually moved toward 
the spinal cord and out of the periphery for the origins of pain, and Gatchnel and Dennis 
(1966) subsequently noted that psychologists examined reasons why pain perceptions 
may change or be lessened.  
According to gate control theory, a link exists between the physical and 
psychological basis for pain (Melzack & Wall, 1965). Pain results from transmission cells 
sending information through the nerve fibers in the spinal cord, which trigger an 
activation system within the brain that lead to a behavioral and physiological process that 
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people experience as pain (Melzack & Wall, 1965). The perception of pain may appear 
greater, less, or completely nonexistent contingent on the emotional state of the person at 
the time (Melzack & Wall, 1965). For example, when an individual is distracted, her or 
his pain may not be as apparent as it is when that individual was stressed in some way 
(Wlassoff, 2014).  With this premise, the gate control theory of pain examines three 
separate systems when considering pain: sensory discriminative, motivational-affective, 
and cognitive-evaluative (Gatchnel & Dennis, 1966). Each of these different interactions 
can influence the level of pain a particular individual may feel at a given time.  
Gate control theory had a significant influence on the scientific and clinical 
community (Gatchnel & Dennis, 1966; Wlassof, 2014). Psychological issues considered 
reactions to pain changed to being thought of as part of the pain processing for which 
new, nonsurgical types of pain control were used. These interventions depended on 
Melzack and Wall’s (1965) observation that the gates in the fibers could inhibit or 
facilitate transmission, depending on activity in either the large or small fibers 
respectively, and that this mechanism was controlled by nerve impulses that could be 
consciously directed by cognitive activity. Using this theory, practitioners suggested that 
individuals could manipulate gates to decrease pain. For instance, chiropractic (Tuchin 
1997) and acupuncture (Jindal et al., 2008) practitioners use gate control to draw on the 
body’s ability to block pain. Biofeedback, the CAM therapy examined in the present 
study, also has its tenets in gate control theory. In the aforementioned instances, health 
care providers used gate control theory to refocus pain perception through additional 
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stimuli to lessen or extinguish pain signals (Labbé & Williamson, 1984). The idea of 
being able to modulate the body’s pain perception through modulation of sensory input 
revolutionized the science of pain and its treatment (McCaffrey et al., 2003; Melzack, 
1993).  
The therapeutic treatment of biofeedback includes the view of pain developed 
through gate control theory (Gatchnel & Dennis, 1996). By directing the mind to 
influence bodily processes, such as skin temperature, heart rate, and breathing, people 
who use biofeedback are able to influence the spinal gating process to block pain (Labbé 
& Williamson, 1984). Gate control theory put into practice in the form of biofeedback 
can be used to lessen the frequency and duration of migraine headache in children (Labbé 
& Williamson, 1984). Because gate control theory holds that psychological and social 
factors influence biological factors, integrating pain control from all directions may 
positively influence treatment outcomes (Borrell-Carrio, Suchman, & Epstein, 2004; 
McInerney, 2015). Integrating gate control theory through biofeedback into the treatment 
of child migraine may prove beneficial when used in conjunction with pharmaceutical 
treatment, which I examined in the present study.  
Literature Review Related to Key Concepts 
Children’s Migraines: Symptomatology and Prevalence 
Among adolescents, 82% say they have experienced a headache before the age of 
15, but only 6% of adolescents experience migraine yearly (Winner, 2009). The 
International Headache Society (2004) changed its diagnostic criteria and classification 
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system in the 2004 International Criteria for Headache Disorders. Migraines are now 
considered a hereditary disorder consisting of neuronal initiation of a cascade of 
neurochemical processes culminating in a spreading wave of cortical neuronal 
depolarization (Lewis, 2009). The updated criteria include developmentally relevant 
amendments that give broader consideration to the pediatric population. This new system 
also takes into consideration the more recent understanding of the physiological changes 
that occur during migraine.  
 According to Winner (2009), migraines experienced in the pediatric population 
have several key features. Pediatric migraines are equally debilitating as those 
experienced by adults but tend to last for a shorter period, from 1 to 72 hours (Winner, 
2009). Furthermore, pediatric migraines are often characterized by bifrontal or bitemporal 
pain, as opposed to unilateral pain (Winner, 2009). Behavioral changes may include 
irritability, mood swings, withdrawn behavior, a loss of appetite, food cravings, and 
frequent yawning (Pezzuto, 2014). Like with general migraines, associated symptoms 
may include nausea, photophobia, phonophobia, difficulty thinking, lightheadedness, and 
fatigue (Winner, 2012). Of key importance, Winner (2012) noted that children may have 
trouble discussing their symptoms; parents or caregivers may need to infer symptoms of 
pediatric migraines, such as nausea, aversion to light, and aversion to sound, based on 
their children’s behaviors. This is especially true for younger children (Brudvik, Moutte, 
Baste, & Morken, 2017).  
21 
 
Social and Academic Aspects of Pediatric Migraines 
The general public may not understand the extent of disability those with 
migraines experience, leading to social stigma (Doheny, 2012). Stigma levels for chronic 
migraine sufferers rival those of individuals with epilepsy and panic attack (Doheny, 
2012). In fact, Thomas Jefferson University’s Headache Center noted that those who 
experienced chronic migraines experienced more stigmas surrounding their illness than 
those who had epilepsy (Doheny, 2012). Those with invisible illnesses like migraine do 
not always “look sick,” which carries the added stigma that the child may be malingering 
(Doheny, 2013). According to Berliner (2012), a neurologist and psychiatrist specializing 
in headache disorders, this type of stigma is a common problem for those with chronic 
migraine. Berliner noted most people who have not experienced migraines incorrectly 
assume taking an over-the-counter pain reliever will adequately address a headache, and 
this is simply not the case with migraine. Without adequate treatment, it may be difficult 
if not impossible for a child with pediatric migraine to function normally (MRF, 2017).  
As with many chronic illnesses, children with chronic migraine are at risk for 
comorbid mental health disorders (MRF, 2017). The loss of control that occurs with 
chronic illness can lead to contributing depression or anxiety in child migraine sufferers 
(MRF, 2017). It is important to keep the child as involved in regular activities as possible 
(Eckes, Radunovich, & Brumbaugh, 2015). Frequent absences from school and social 
activities because of migraines can have a significant negative effect on the child’s ability 
to feel connected and productive (Eckes et al., 2015). This, in turn, causes stress, which 
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leads to more migraines (Eckes et al., 2015). Care should be taken not to engage in this 
frustrating cycle, and special education supports within the school, such as a 504 Plan or 
even an Individual Education Plan for Health Impairment, should be considered (Eckes et 
al., 2015). Health education regarding the etiology and disability that accompany 
migraine illness is also recommended to combat comorbidity associated with pediatric 
migraines (Eckes et al., 2015).  
Diagnoses of Migraines in Children 
The initial evaluation of children with migraine should start with an in-depth 
medical history along with a thorough physical and neurologic workup (Winner, 2012). 
The use of further diagnostic testing, such as neuroimaging, may rule out other conditions 
or disorders (Winner, 2012). Because children may have trouble with explaining their 
pain levels, pain scales, such as face or numerical scales, may help to gain a more 
accurate picture of pain levels of children (Winner, 2009, 2012). In addition, parents and 
caregivers are often relied on to supplement the account of a child’s pain levels (Brudvik 
et al., 2017; Winner, 2012).  
Several barriers exist to receiving an initial migraine diagnosis for children. 
Making the diagnosis of migraine in this population is difficult because of the types of 
symptoms, which can change markedly throughout childhood (Lewis, 2009). Often, 
migraines in children do not always manifest in head pain (Pazuto, 2014). Nausea, 
vomiting, and abdominal pain may accompany the head pain with migraine or may 
manifest in absence of it (Pezzuto, 2014). Behavioral changes may also be seen in the 
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prodromal phase or first phase of a migraine episode, which may complicate an accurate 
diagnosis (Lissandrello, 2014). Therefore, the diagnostic criteria established by the 
International Classification of Headache Disorders-II are at times inadequate for 
diagnosing pediatric migraines (Winner, 2012). 
An additional problem is that medical professionals may underestimate children’s 
complaints of pain (Brudvik et al., 2017). Children’s complaints may be dismissed as 
“just a virus” or a plea for attention (Masters, 2006). In fact, as recently as the 1980s, 
pediatric textbooks did not talk about pain management for children at all (Schechter, 
Berde, & Yaster, 2003). It was believed that children did not experience pain like adults 
because of an undeveloped neurological system (Roberts & Steele, 2009). In addition, 
there are conflicting antiquated philosophies through which practitioners view pain; 
either it is “real” or the child is “malingering” (Robbins, Smith, Glutting, & Bishop, 
2005). Such views can lead poorly informed professionals to dismiss children’s pain and 
erroneously label them with psychological disorders because their pain is not clearly tied 
to physical pathology; these children are unnecessarily given medications and medical 
procedures rather than empirically supported approaches to deal with their presenting 
illness (Masters, 2006). More than half of all migraine sufferers are never diagnosed 
(MRF, 2017). Frustrated parents are left to address their child’s migraines by 
administering over-the-counter medications, only to find them useless in alleviating their 
child’s pain. As of 2017, there are 500 certified headache specialists within the United 
States and 38 million people who have migraines (MRF, 2017).  
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Parent Role in Pain Control for Children with Migraines 
Having a sick child is distressing; parents of children with a chronic illness 
reported much greater general parenting stress than those parenting healthy children 
(Cousino & Hazen, 2013). Depending on health care workers to communicate the 
disposition of a child’s illness leaves parents with a multitude of conflicting information 
and diverse opinions, resulting in anxiety and confusion (Levetown, 2008). However, 
parents of children with migraines often serve at the front lines of pediatric migraine 
treatment (Brudvik et al., 2017).  
Because of their unique position in the treatment of child migraine, parents and 
caregivers are often the first observers of pain and symptom improvement (Craig et al., 
1996). Parents know their children’s typical pain-related behaviors better than those who 
are unfamiliar with them; living in the home with the child and observing their level of 
functioning during lengthy periods of time when migraines may be active gives parents a 
baseline with which to compare children’s pain behaviors and overall level of functioning 
(Brudvik et al., 2017; Solodiuk & Curley, 2003; Solodiuk et al., 2009). Moreover, in an 
unfamiliar place, like an emergency room or a doctor’s examination room, a child may 
not feel comfortable expressing him or herself to the medical staff attending them 
(Brudvik et al., 2017). Thus, a parent must advocate for their child to ensure they receive 
the best treatment for their pain. Moreover, parents and caregivers may serve as 
important data sources in understanding and managing children’s pain (Craig et al., 1996; 
Winner, 2012).  
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Pharmaceutical Treatments for Children with Migraines 
Several pharmaceutical treatments may be prescribed to children with migraines. 
The typical pharmaceutical treatment of pediatric migraine requires a three-pronged 
approach: (a) integration of migraine friendly behavioral practices, (b) medication for 
addressing acute migraine treatment, and (c) daily preventive medications as needed 
(Lewis, 2002). The acute treatment medications of migraine most researched are 
ibuprofen, acetaminophen, and sumatriptan nasal spray (Winner, 2009). For preventive 
treatment in children with frequent, disabling migraines, antiepileptic agents topiramate, 
disodium valproate, levetiracetam, the antihistamine cyproheptadine, and the 
antidepressant amitriptyline are typically used. However, these medications are not 
without significant side-effects that can affect the developing brain.  
Antiepileptic agents have positive outcomes for migraine prevention but come 
with potentially severe side effects. Topiramate is an antiepileptic drug effective in 
treating many neuropsychiatric disorders and is used as a migraine preventative approved 
for children’s use (Mula, 2012). Cognitive dysfunction is observed in patients who take 
it; memory impairment, significant decrease in psychomotor reaction time, parathesia, 
concentration problems, as well as behavioral disturbances occur in children administered 
this drug (Mula, 2012). Disodium valproate is an anticonvulsant drug approved for use in 
children for migraine and epilepsy (Egger & Brett, 1981). Side effects of this drug 
include severe weight gain, gastrointestinal disturbance, liver disease, pancreatitis, hair 
loss, tremor and blood coagulation issues, and eneuresis (Egger & Brett, 1981). 
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Levetiracetam, sold under the brand name Keppra, is also an antiepileptic drug that 
moderates the transmission of nerve impulses to the brain (Everyday Health, 2017). 
Common side effects from this medication include weakness, dizziness, irritability, 
becoming aggressive, decreased appetite, sleepiness, and developing Stevens-Johnson’s 
syndrome; in addition, some children may develop psychotic symptoms and hallucinate 
(Everyday Health, 2017).  
Additional pharmaceutical treatments involve the use of antihistamines or 
antidepressants. Cyproheptadine or periactin is an antihistimine preventative medication 
given to children for migraine (Marks, 2017). It can cause weight gain, blurred vision, 
constipation, drowsiness, excitability, nausea, and restlessness (Marks, 2017). 
Amitriptyline is an antidepressant prescribed to children for migraine prevention. It is an 
older tricyclic antidepressant associated with irregular heart rhythms, dizziness 
constipation, and weight gain (About Kids Health, 2018).  
Although a pediatric neurologist may be able to recognize and correctly diagnose 
migraine in children (Winner, 2009), many pharmacological treatment options that are 
among the first lines of defense may have many undesirable negative side effects (Papetti 
et al., 2010; Winner, 2009). Children are physiologically different from adults and 
metabolize medication differently (Jindal et al., 2008). Their bodies are still growing and 
developing; they may be more at-risk when taking different classes of pharmaceuticals 
(Papetti et al., 2010). The severity and frequency of the migraine incidences must be 
considered to justify the use of these migraine preventative medications.  
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Nevertheless, Lewis (2004) noted that data regarding pharmacologic treatment of 
migraine in children were limited.  Integration of a nonpharmaceutical treatment, like 
biofeedback, may be prudent in helping a child to manage pain. However, a gap in the 
literature exists regarding the use of biofeedback in conjunction with pharmaceutical 
intervention among children with migraines. The following section includes a review of 
CAM therapies, in general, to lead into the discussion of CAM therapies as a complement 
to pharmaceutical treatments.  
CAM Therapies  
It is common for those with chronic pain to look for other solutions to help 
address their pain beyond traditional medications (Woolston, 2017). Traditional 
treatments for pain, like narcotics, have decreased because of the opioid misuse epidemic, 
which further highlights the need for other effective alternatives for pain management 
(Millstine, et al., 2017).  CAM, more recently referred to as complimentary integrative 
medicine (CIM), are add on treatments to traditional medical therapies (Woolston, 2017). 
Many pain centers incorporate acupuncture, biofeedback, massage, and hypnosis into 
their treatment practices to further address pain (Woolston, 2017).  
The National Center for Complementary and Integrative Medicine shows a 
steadily growing amount of data support CAM therapies when used in addition to 
traditional medical care (Millstine et al., 2017). The use of CIM is increasing; in Europe, 
headache clinics report an 81.7% use of various CIM techniques (Millstine et al., 2017). 
Biofeedback, in particular, shows promise as a useful CIM therapy. A meta-analysis of 
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94 studies and 3,500 participants regarding biofeedback techniques using peripheral skin 
temperature feedback, blood, volume pulse feedback, and electromyography reflected a 
significant medium sized effect on the frequency, duration, and intensity of migraine 
headaches (Nestoriuc & Martin, 2007). 
Case for CAM to Complement Pharmaceutical Therapies 
After a child is diagnosed formally with migraine and the doctor establishes a 
medication regiment, parents may wish to consider complimentary therapy. As the name 
suggests, complimentary therapy compliments, or goes along with, another form of 
therapy simultaneously. Lewis (2002) explained behavioral modification is already used 
as a method of treating migraines; a noninvasive intervention, such as biofeedback, may 
further improve outcomes. In the case of biofeedback and the migraine patient, as the 
patient learns to monitor his or her physiological condition, he or she is better able to 
stave off the triggers that herald the coming of the migraine and thereby prevent or lessen 
its effects (Lipchik, 2008).  
Researchers have noted several benefits of CAM therapies. For example, CAM 
may improve the efficacy of migraine treatment. Lipchick (2008) determined that when 
either biofeedback or Inderal were used by themselves, a 55% reduction in migraines 
occurred, but when used together, the average improvement increased to 70%. 
Researchers have found that through complimentary therapies, less medications are 
needed to achieve the desired therapeutic effect (Nestoriuc et al., 2008). Thus, the 
conjunction of CAM and pharmaceutical treatment in treating pediatric migraine may 
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reduce the amount of medication required to treat pain and improve the efficacy of that 
treatment (Nestoriuc et al., 2008).  In the following section, I further detail biofeedback, a 
CAM therapy.  
Role of Pain and Biofeedback in Treating Pediatric Migraine 
Biofeedback is an effective treatment for migraine among adults. In a meta-
analysis done by Nestoriuc and Martin (2007), the researchers reviewed 55 studies that 
revealed improved migraine symptoms over more than 17 months. Reduced frequency of 
migraine episodes and perceived self-efficacy were outcomes in the studies. Of the three 
types of biofeedback used in the reviewed studies, Nestoriuc and Martin found blood-
volume-pulse feedback yielded the highest effect sizes compared with peripheral skin 
temperature feedback and electromyography feedback. Additional researchers have found 
biofeedback effective for migraine treatment with symptom improvement in 40% of 
subjects (Blanchard et al., 1980; Blanchard & Andrasik, 1987; Penzien et al., 1985).  
Although research supports the use of biofeedback to compliment migraine 
treatment for adults, a dearth of literature supports its use for children. However, children 
can be taught to do biofeedback and experience success (Allen & Shriver, 1998). After 
children become aware of the physiological changes that precede migraine and learn how 
to control them through biofeedback, they can improve and lower their frequency of 
migraine episodes (Allen & Shriver, 1998). Because children are more vulnerable to the 
side effects of the medications often prescribed for migraine (Mula, 2012), using 
30 
 
biofeedback as an alternative or compliment to medication offers another way to bring 
improvement to a difficult-to-treat illness (Nicholson, Buse, Andrasik, & Lipton, 2011).   
Influence of Demographics on Migraines and Biofeedback 
Socioeconomic status. Access to care for those of lower socio-economic status 
(SES) was a significant concern. Higher SES is associated with higher prevalence of 
migraines in a household (Le, Hansen, Skytthe, Kyvik, & Olesen, 2011; Stewart, Roy, & 
Lipton, 2013). The income levels of pediatric migraine sufferers directly influence their 
access to proper care. Lower income level families were less likely to seek medical care 
and less likely to get quality care when they did. Complimentary medical care, such as 
biofeedback, were rarely covered by insurance companies, which made it out of reach for 
most lower- and middle-income families.  
Age.  Age of a pediatric migraine sufferer can influence the ability to articulate 
symptoms. Younger children are not able to voice their discomfort verbally and may need 
caregivers to interpret for them (Brudvik et al., 2017). Older children may mask their 
discomfort and present as if they have a mood disorder. All ages should be taught to their 
best ability to articulate their symptoms for health care professionals to adequately assist.  
Gender. Migraines occur more often in males during childhood (Pezzuto, 2014; 
Winner, 2012). It is not known why males tend to have more migraines during childhood. 
During adolescence, females tend to have higher incidence of migraine, which continues 
into adulthood (Pezzuto, 2014; Winner, 2012). Females are thought to have more 
migraine onset in adolescence because of fluctuating hormone levels associated with the 
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menstrual cycle (Pezzuto, 2014; Winner, 2012). 
Summary and Conclusions 
Migraine illness treated with medication in conjunction with biofeedback in adults 
has been successful (Nestoriuc & Martin, 2007). Comparatively, less research exists 
regarding children and pharmacologic therapy for migraine (Lewis, 2004). Although 
some study findings demonstrated biofeedback is useful in migraine treatment for 
children (Allen & Shriver, 1998; Herman & Blanchard, 1997; Labbé & Williamson, 
1984), no research has compared biofeedback and medication to medication alone 
through the input of a parent. Parent input is key because pain observations of parents are 
often more accurate than those of health care professionals (Brudvik et al., 2017; Craig et 
al., 1996). By conducting a study to determine whether medication and biofeedback or 
medication alone alleviates children migraine symptoms best through the input of 
parents, I helped to fill a gap in the existing literature on the subject of complementary 
migraine treatment for children. Chapter 3 will include an outline of the methodology 
used for the purpose of this study.  
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Chapter 3: Research Method 
Introduction 
Little literature exists on child migraine sufferers’ parent perceptions regarding 
the improvement of symptoms of their illness when comparing conventional medical 
treatment to those of a complimentary nature. The purpose of this quantitative study was 
to measure effectiveness of biofeedback as a complementary therapy in child migraine 
patients, as shown through surveys completed by caregivers. This chapter contains a 
review of the research design, methodology, population, and sample selection.  
Research Design and Rationale 
In this study, I employed a quantitative methodology with a quasi-experimental 
research design. As a research tool, quantitative methodology was first used in 1250 A.D. 
when experimenters felt it was important to quantify their data (Williams, 2007). Since 
then, quantitative research has been the primary research method of choice throughout 
Western culture (Williams, 2007). This type of research is built from existing theory and 
the data collected are used to objectively measure reality (Williams, 2007). Results 
obtained through quantitative research are meaningful because of the objectivity of the 
data collection process (Williams, 2007). Through the quantitative methodology, data 
that represents key outcomes can be measured and statistically analyzed, which allows 
for hypothesis testing in an empirical manner (Williams, 2007). 
 My study was quasi-experimental because of the nonrandom selection of 
participants. The design choice was necessary because of the relative rarity of 
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participants who fit the design criteria. Child migraine patients can be difficult to 
determine or access, and because this control was somewhat limited, experimentation in 
the truest form was not possible. This limited the validity of the study to some degree.  
The quantitative methodology used for this study was in contrast to the qualitative 
and mixed methods approaches that are less structured and more involved in describing 
and explaining the data on a first-hand basis and would have heavily involved the 
researcher in the actual experiences of the participants. These approaches were not 
appropriate; such close involvement with study participants could have biased the results. 
A quantitative, objective approach using numerical data ensured objectivity and validity. 
As such, the quantitative methodology was more appropriate because of its objectivity 
and focus on numerical data. 
 The quasi-experimental research design involves the nonrandom assignment of 
study participants to groups. The opposite design is a true experimental design, which 
involves randomly assigned participants. In this study, the self-selected groups consisted 
of parents who were treating their children’s migraines with medication alone or 
medication plus biofeedback treatment. The use of a true experimental design was not 
practical because it would have involved withholding a medical treatment from some 
members of the sample. I employed two mixed model ANCOVAs to assess group 
differences over time. The between-subjects factor was treatment (i.e., biofeedback and 
medication vs. medication alone), and the within-subjects factor was time (i.e., pre and 
post). The dependent variables were frequency of migraines and intensity of migraines. 
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This design allowed me to target the response of those who were most able to give the 
best report of child migraine response to treatment because parents are thought to be most 
accurate at judging their children’s responses to pain. As such, this design aided in 
advancing knowledge in the areas of pain response to migraine treatment. 
Methodology 
Population 
 The population consisted of parents and caregivers of children who have 
experienced migraine episodes and who were treating those migraines. Approximately 
10% of school-aged children in the United States suffer from migraines (MRF, 2017). 
Furthermore, migraine attacks have been diagnosed in children as young as 18 months 
old, and infant colic is being investigated as a possible form of migraine (MRF, 2017). 
Parents of child migraine sufferers often have migraines themselves and have a 50% 
chance of passing the trait to their offspring (MRF, 2017).  
Sample and Sampling Procedures 
 I used convenience sampling to recruit participants for this study. This process 
involved advertising the link to the study survey through online and in-person migraine 
support groups and word-of-mouth referrals to the link to the survey. Truly random 
sampling was not practical because the population was highly specialized. Participants 
were contacted through their responses to the survey links. The study only included 
parents or caregivers of children diagnosed with migraine up to the age of 18 years old 
who had treated their migraines with medication only or medication in conjunction with 
35 
 
biofeedback for participation. Potential participants had a child under the age of 18 years 
old at the time of the study who experienced migraine episodes and received either 
medication only treatment or medication and additional biofeedback therapy for their 
migraines. Participants who had children older than the age of 18 years old; children who 
had not been formally diagnosed with migraine; or treated with another therapy, such as 
acupuncture or hypnosis, were not included in the study.  
 I determined the appropriate sample size for this study through G*Power, a power 
calculator. For the determination of an appropriate power level or sample size, Cohen 
(1988) recommended a medium effect size and a .80 power level. For mixed models 
ANCOVA with one independent variable with two groups, two time measurements, three 
covariates with a total of six groups, a medium effect, and a generally accepted power 
level of .80, 96 participants would be necessary (see Faul, Erdfelder, Buchner & Lang, 
2008). However, in similar studies, researchers found large effect sizes (Herman & 
Blanchard, 2002; Stokes & Lappin, 2010). When assuming a large effect size, a mixed 
model ANCOVA with the previously specified information would require 48 
participants.   
Procedures for Recruitment, Participation, and Data Collection 
 Potential participants self-identified by responding to a link connected to migraine 
support group sites. This link sent them to the study survey, hosted on SurveyMonkey. 
The link also contained a description of the study, what their participation would look 
like, and a description of how their information would be used. If the potential participant 
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clicked on the link, they were taken to an informed consent page on SurveyMonkey that 
contained the complete informed consent document, which detailed the nature of the 
study, participants’ rights, my contact information, the voluntary nature of the study, and 
the maintenance of confidentiality. In a question at the end of this page, I asked whether 
they understood and agreed to provide their informed consent. If they answered yes, they 
were indicating they provided their informed consent to participate in the study and were 
directed to the survey. Participants who answered no were redirected to a page that 
thanked them for their time; they were not allowed to take the survey. Appendix A 
includes the recruitment materials; Appendix B includes the informed consent form.  
 Participants received a short demographic survey that requested information 
regarding their age, gender, and SES. First, the survey asked whether their child was 
under the age of 18 years old, had migraines, and was being treated for the migraines. A 
negative response to that question disqualified the participant from the study, and they 
were taken to a thank you page for their time. The survey then asked whether the child 
was being treated using medication only or medication plus biofeedback therapy. The 
survey also asked how many migraines their child had 1 month before the intervention 
and how many migraines their child had 1 month following treatment. Participants were 
then presented with the INRS (Solodiuk & Curley, 2003) twice. In the first iteration, I 
directed participants to think of their child’s migraines before treatment. In the second 
iteration, participants were directed to think of their child’s migraines after treatment. 
After successful completion of the survey, participants were thanked for their time and 
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again provided with my contact information. After an appropriate number of survey 
responses, I closed the survey and downloaded the data from SurveyMonkey. The data 
did not contain any identifying information and are kept on a password-protected 
computer, accessible only by me and my committee.  
Instruments and Operationalization of Constructs 
 The instruments used in this study were a demographic survey and the INRS. In 
the following subsections, I detail these instruments. The constructs measured by the 
study variables are operationalized following a description of the instruments. 
 Demographic survey. I created the demographic survey used in this study to ask 
questions regarding the sampling frame (i.e., whether the participant’s child has 
migraines), how the child was treated for the migraines, as well as their gender and age. 
The survey also asks for the gender, age, and SES of the parent completing the survey. I 
used this survey to gather data for the dependent variables of frequency of migraines and 
treatment type. Appendix C includes a copy of this survey. 
 INRS. Solodiuk and Curley (2003) created the INRS and designed it to describe 
the numerical intensity of pain the child experiences using responses given by a parent or 
nurse attendant. I specifically chose the INRS because of its personalized assessment tool 
based specifically on the parents’ knowledge and assessment of their child. The INRS 
was based on nonverbal responses by the child observed by the parent (Solodiuk & 
Curley, 2003). As such, this assessment was appropriate for younger nonverbal children 
and those who do not communicate well in medical settings. According to Solodiuk et al. 
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(2010), preliminary data for reliability and validity of this instrument were good for 
assessing pain in nonverbal children with a severe intellectual disability in an acute care 
setting. Solodiuk et al. indicated that interrater reliability was high (i.e., ICC 0.82–0.87) 
and that the instrument had strong convergent validity (r > .60). I obtained permission 
from the copyright holder to use this instrument (see Appendix D). Appendix E includes 
a copy of the scale.  
 Independent variables. This study involved two categorical independent 
variables: treatment type and time.  
 Treatment type. The independent variable of treatment type was measured by the 
demographic survey item that asked: “What type of treatment does your child receive for 
their migraine?” This was a dichotomous variable with the categories of medication only 
and biofeedback plus medication.  
 Time. The second variable was elapsed treatment time, measured at two time 
points: pre and post.  
 Dependent variables. Two dependent variables were included in this study: 
migraine frequency and migraine intensity.  
 Migraine frequency. The dependent variable of frequency of migraines was 
measured by the demographic survey items that asked: “How many migraines did your 
child experience 1 month before treatment?” and “How many migraines did your child 
experience 1 month after treatment?’ This was a continuous variable where participants 
could indicate exactly how many migraines were experienced. As this study was set up 
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using a repeated measures design, the dependent variable consisted of two measurements: 
pre and post.  
 Migraine intensity. I measured the dependent variable of intensity of migraines 
using the INRS. This instrument consists of 0-10 rating scale, with higher scores 
representing a greater intensity and pain of a migraine. The identification of specific 
behaviors are used to help score the pain intensity and categorize the amount of pain the 
child is experiencing. Each response is categorized into its own outcome section to 
clearly describe the response and how it has been measured. As participants completed 
the INRS twice, once in regard to before their child’s treatment and once in regard to 
after their child’s treatment, I obtained scores for pre and post.  
 Covariates. Several control variables were included. These categorical variables 
accounted for potential confounding variables. ANCOVA presumes covariates are 
quantitative.  
 Gender. Child’s gender was a categorical control variable, with categories of 
male and female.  
 Child’s age. Child’s age was a categorical control variable. The age categories 
were birth to 12 years, and 13 to 18 years.  
 Socioeconomic status. SES of the family was a categorical control variable. The 
categories were lower to middle ($124,999 and below) and upper ($125,000 and above).  
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Data Analysis Plan 
 After downloading the data from SurveyMonkey, I uploaded it to IBM’s  
Statistics software (SPSS). I used SPSS for all data management and analysis. The data 
were assessed for significant cases of missing data. Cases missing more than 50% of data 
were removed. Outliers on continuous variables were assessed using the guidelines 
suggested by Tabachnick and Fidell (2013), in which standardized scores are created and 
then assessed for values beyond ± 3.29. Values beyond this number suggest that the 
associated score is an outlying value. I considered outliers for removal.  
 I then conducted descriptive statistics. Next, I calculated means and standard 
deviations for the continuous variables and calculated frequencies and percentages for 
categorical variables. The following sections present the analyses used for hypotheses 
testing.  
Omnibus Research Question: Is biofeedback in addition to medication treatment 
more effective in the treatment of child migraines than medication alone? 
H0: Biofeedback in addition to medication is not more effective in the 
treatment of child migraines than medication alone. 
Ha: Biofeedback in addition to medication is more effective in the 
treatment of child migraines than medication alone. 
Research Subquestion 1: Does biofeedback in addition to medication treatment 




H01: Biofeedback in addition to medication does not reduce the frequency 
of reported child migraines when compared to medication alone. 
Ha1: Biofeedback in addition to medication does reduce the frequency of 
reported child migraines when compared to medication alone. 
Research Subquestion 2: Does biofeedback in addition to medication treatment 
reduce the intensity of reported child migraines when compared to medication 
alone? 
H02: Biofeedback in addition to medication does not reduce the intensity 
of reported child migraines when compared to medication alone. 
Ha2: Biofeedback in addition to medication does reduce the intensity of 
reported child migraines when compared to medication alone. 
I answered the omnibus research question based on the answers to the sub-
research questions. The sub-research questions were answered using two mixed models  
ANCOVAs. This is the appropriate analysis to perform when seeking to assess group 
differences in a single continuous dependent variable while controlling for potentially 
confounding variables (Field, 2013). Prior to each analysis, I assessed the assumptions of 
the mixed models ANCOVA. The first assumption is that of normality, assessed using a 
Kolmogorov-Smirnov (KS) test. If the KS test is not significant, normality can be 
assumed (Tabachnick & Fidell, 2013). The second assumption is that of homogeneity of 
variances, assessed using Levene’s test. As with the KS test, if Levene’s is not 
significant, the assumption is met (Tabachnick & Fidell, 2013). Sphericity is the third 
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assumption, measured by Mauchley’s test of sphericity. If Mauchley’s test is not 
significant, sphericity can be assumed and the assumption is met (Tabachnick & Fidell, 
2013).  
For each ANCOVA model, findings for the main effect of time (i.e., pre and post 
scores on the dependent variable) and the main effect of treatment type (i.e., biofeedback 
plus medication and medication alone) were reported. The covariates of child’s age, 
child’s gender, and family socioeconomic status were control variables. An interaction 
term between time and treatment type was included in the model. If this interaction term 
was significant at p < .05, it indicated a significant difference between groups over time 
(Field, 2013) and provided support for the rejection of the null hypothesis. The first 
ANCOVA was used to answer Sub-Research Question 1 and included the dependent 
variable of frequency of migraines. The second ANCOVA was used to answer Sub-
Research Question 2 and included the dependent variable of intensity of migraines. I used 
the results of both models to evaluate the omnibus research question. If the null 
hypothesis for each sub-research question is rejected, then the omnibus null hypotheses 
can be rejected.  
Threats to Validity 
 Internal validity refers to the possibility of the effects being observed in a study as 
a result of the changing of the independent variable and not some other factor (McCleod, 
2013). This means a causal relationship exists between the independent and dependent 
variables. A possible threat to internal validity in this study was the length of time 
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between treatment onset and the participant’s completion of the survey. The internal 
validity improved by controlling for the confounding variables of age, gender, and SES. 
 External validity refers to the extent to which the results of a study can be 
generalized to other settings, other people, and over time. Threats to external validity 
include the lack of a truly random sample because of the specialized participant 
population (McCleod, 2013). A random sample was beyond the score of the current study 
and posed a limitation to external validity. Additionally, threats to external validity tend 
to occur when generalizations are made to inappropriate populations (McCleod, 2013). 
As such, I did not generalize beyond the populations from which the data were sampled.  
Ethical Procedures 
 The American Psychological Association (2010) mandates that researchers make 
the ethical protection of their subjects a priority. All subjects were required to read and 
sign a detailed consent form that fully disclosed their rights as participants and their 
ability to ask questions at any point during the study. My contact information was 
included as well as the research purpose, procedures, risks and benefits of participation, 
and rights to confidentiality and privacy. Participation in the research was completely 
voluntary and the participants could withdraw from the study at any time without 
negative repercussions.  
 This study pertained to children with a chronic health condition and, as such, they 
may be considered a potentially sensitive population that requires additional care. I 
gathered information gathered through the parents and caregivers of these children to 
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minimize any potential negative effects from the study. I completed the IRB application 
to gain approval before conducting research. The information contained in the application 
illustrates the positive aspects of conducting this study outweighed the potential for 
negative outcomes. I also ensured that the procedures used in this study focused on the 
use of the ethical principles of beneficence, justice and personal respect (American 
Psychological Association, 2010). Data are stored electronically on a password-protected 
personal computer to which only I have access. All data used in the study will remain 
confidential and anonymous.  
Summary 
 This chapter included the research questions and hypothesis for the purpose of the 
study. I also detailed the operational definitions that support the study and the theories 
employed herein. The quasi-experimental research design involves nonrandom selection 
of study participants. I conducted two mixed model (one-within one-between) analyses of 
covariance (ANCOVAs) to assess group differences over time. The independent variable 
was treatment (biofeedback and medication vs. medication alone). The dependent 
variables were frequency of migraines and intensity of migraines. I discussed the aspects 
of validity and potential threats as well as reviewed participant recruitment, eligibility, 




Chapter 4: Results 
Introduction 
The purpose of this quasi-experimental quantitative research was to determine if a 
difference in treatment perception was apparent between the parents of children who 
received biofeedback and medication or medication only for treatment of their chronic 
migraines. Through this study, I measured the effectiveness of biofeedback as a 
complementary therapy in child migraine patients using surveys completed by parents 
and caregivers. The following research questions and hypotheses guided the study: 
Omnibus Research Question: Is biofeedback in addition to medication treatment 
more effective in the treatment of child migraines than medication alone? 
H0: Biofeedback in addition to medication is not more effective in the 
treatment of child migraines than medication alone. 
Ha: Biofeedback in addition to medication is more effective in the 
treatment of child migraines than medication alone. 
Research Subquestion 1: Does biofeedback in addition to medication treatment 
reduce the frequency of reported child migraines when compared to medication 
alone? 
H01: Biofeedback in addition to medication does not reduce the frequency 
of reported child migraines when compared to medication alone. 
Ha1: Biofeedback in addition to medication does reduce the frequency of 
reported child migraines when compared to medication alone. 
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Research Subquestion 2: Does biofeedback in addition to medication treatment 
reduce the intensity of reported child migraines when compared to medication 
alone? 
H02: Biofeedback in addition to medication does not reduce the intensity 
of reported child migraines when compared to medication alone. 
Ha2: Biofeedback in addition to medication does reduce the intensity of 
reported child migraines when compared to medication alone. 
  I conducted two mixed-model ANCOVAs to test the research questions and 
corresponding hypotheses. The results of the study are organized in this chapter into three 
corresponding sections: data collection, results, and summary of findings. In the data 
collection section, I review responses of participants, statistical discrepancies, and 
various characteristics of those participants involved in the survey process. In the results 
section, I present a report of the findings of the statistical calculations.  
Data Collection 
 Data collection began June 4, 2018 shortly after I received IRB approval on May 
24, 2018 (Approval Number: 05-24-18-0152150) and ceased August 15, 2018. I used the 
online survey tool SurveyMonkey to recruit participants using the Audience feature, 
which targeted specific participants in SurveyMonkey’s large participant pool to 
complete this survey. I found that many of the responses gained through this medium 
were incomplete and, therefore, not useable.   
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I posted a survey link in migraine support groups and public areas, such as coffee 
shops near university campuses. The responses to the link yielded more complete data 
than those of the Audience feature of SurveyMonkey. Average time to complete the 10-
question survey was 1 minute and 31 seconds, according to SurveyMonkey data. In total, 
the survey yielded 56 participants. I postulated that those who were more familiar with 
migraine in children were more intrinsically motivated to answer the less than 2-minute 
survey more fully and completely than those randomly assigned the survey through 
Audience. Data collection occurred as planned with little to no variation from initial 
expectations.  
Data Management 
 I extracted data from SurveyMonkey, coded the data, and imported them into 
SPSS Version 25. Through SPSS, I assessed the data for missing data and outliers. Three 
cases were removed for missing data. Outliers are values that have a corresponding 
standardized score with an absolute value higher than 3.29 (Tabachnick & Fidell, 2013). 
One case contained an outlier and was removed from the data set.  
Descriptive Statistics 
  I performed descriptive statistics to characterize the sample. Frequencies and 
percentages for categorical variables were then calculated. Next, I calculated means and 
standard deviations for continuous variables.  
 Frequencies and percentages. Table 1 presents full frequencies and percentages. 
Most parents’ children were treated with medication only (n = 28, 54%). The majority of 
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parents or caregivers who responded to the survey were female (n = 36, 69%). Most of 
the children in question were also female (n = 31, 60%). Most families were considered 
middle class ($42,000–125,000; n = 27, 52%).  
 Means and standard deviations. Table 2 presents the minimum, maximum, 
mean, and standard deviation of parental and child ages. On average, the parents who 
responded were 43.52 years of age (SD = 9.56 years). Their children were, on average, 
11.96 years old (SD = 4.73 years).  
Table 1 
Frequency Table for Categorical Variables 
Variable n % 
Treatment     
    Medication only 28 53.85 
    Biofeedback and medication 24 46.15 
    Missing 0 0.00 
Parent gender     
    Male 16 30.77 
    Female 36 69.23 
    Missing 0 0.00 
Child gender     
    Male 21 40.38 
    Female 31 59.62 
    Missing 0 0.00 
Socioeconomic class     
    Lower: Below $42,000 8 15.38 
    Middle: $42,000-125,000 27 51.92 
    Upper: Over $125,000 17 32.69 
    Missing 0 0.00 
Note. Due to rounding errors, percentages may not equal 100%. 
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Table 2  
Summary Statistics for Parent and Child Age 
Variable Min Max M SD 
Parent age 24.00 60.00 43.52 9.56 
Child age 1.00 17.00 11.96 4.73 
 
Results 
 To answer this omnibus research question, I created two research subquestions 
involving the frequency and intensity of reported child migraines, respectively. I 
addressed these research questions using two ANCOVAs. These ANCOVAs each had 
independent variables of treatment type (i.e., medication only or biofeedback plus 
medication), time (i.e., before and after treatment), covariates of child’s gender (i.e., male 
or female), child’s age (i.e., continuous), and SES (i.e., lower to middle [$124,999 and 
below] or upper [$125,000 and above]). The dependent variables were child migraine 
frequency and intensity, respectively. Prior to interpreting the results of the ANCOVAs, I 
performed assumption testing.  
 I assessed the assumption of normality for the continuous variables for each level 
of each categorical variable using KS tests. Table 3 presents the results of the KS tests. 
The KS tests were significant for several combinations of variables, indicating normality 
was not met for those variables. However, the KS test can be sensitive to sample size and 
often gives false positive results (Ghasemi & Zahediasl, 2012). Additionally, the F test 
used in ANOVA procedures is robust against nonnormality (Stevens, 2009; Tabachnick 
& Fidell, 2013).  
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 I assessed homogeneity of variances through Levene’s test. Levene’s test was not 
significant for the first ANCOVA (p = .148 and p = .286) and was not significant for the 
second ANCOVA (p = .085 and p = .119). These findings indicated the assumption of 
homogeneity of variances was met for both analyses. Although sphericity is a common 
assumption of repeated measures analyses, it was not applicable in this case because only 
two time points were measured (see Tabachnick & Fidell, 2013).  
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Table 3  
Results of KS Tests 
Continuous variable Categorical cariable D p 
 Treatment type:   
Frequency before treatment Medication only 0.14 .159 
 Biofeedback 0.17 .059 
Frequency after treatment Medication only 0.20 .005 
 Biofeedback 0.15 .154 
Intensity before treatment Medication only 0.20 .005 
 Biofeedback 0.25 .000 
Intensity after treatment Medication only 0.14 .168 
 Biofeedback 0.24 .001 
Child’s age Medication only 0.19 .012 
 Biofeedback 0.19 .020 
 Gender:   
Frequency before treatment Female 0.13 .191 
 Male 0.17 .133 
Frequency after treatment Female 0.14 .129 
 Male 0.28 .000 
Intensity before treatment Female 0.20 .003 
 Male 0.26 .001 
Intensity after treatment Female 0.28 .000 
 Male 0.16 .176 
Child’s age Female 0.17 .019 
 Male 0.17 .139 
 Socioeconomic class:   
Frequency before treatment Lower to middle class 0.14 .088 
 Upper class 0.26 .003 
Frequency after treatment Lower to middle class 0.13 .145 
 Upper class 0.21 .044 
Intensity before treatment Lower to middle class 0.24 .000 
 Upper class 0.19 .117 
Intensity after treatment Lower to middle class 0.19 .002 
 Upper class 0.21 .044 
Child’s age Lower to middle class 0.16 .020 




Research Subquestion 1 
 The main effect for treatment type was significant, F(1, 47) = 5.21, p = .027, 
indicating significant differences in migraine frequency among the values of treatment. In 
other words, without taking into account the repeated measurements, differences occurred 
in migraine frequency between treatment types. Those who took medication only had 
significantly less migraine frequency on average than those who also took biofeedback. 
On average, between time points, those who took medication only had 1.14 fewer 
migraines per month. Table 5 presents full descriptive statistics for each treatment type 
and time point.  
  The main effect for the within-subjects factor (time) was significant, F(1, 47) = 
5.92, p = .019, indicating significant differences in migraine frequency 1 month before 
and 1 month after treatment. In other words, without taking into account what type of 
treatment was received, a significant difference occurred from before and after treatment. 
Both medication only and medication plus biofeedback groups experienced a significant 
decrease in migraine frequency over time. On average, participants reported 1.39 fewer 
migraines from before to after (see Table 5).  
 The interaction effect between the within-subjects factor and treatment type was 
not significant, F(1, 47) = 0.28, p = .600, indicating no significant differences in migraine 
frequency between treatment types and time points. In other words, medication plus 
biofeedback does not seem to be more effective than medication alone in reducing 
migraine frequency. The null hypothesis for Research Subquestion 1 was not rejected. 
53 
 
Table 4 presents the ANCOVA results, while Table 5 presents means and standard 
deviations for each factor level combination and row and column averages. 
Table 4  
Results of Mixed Model ANCOVA Involving Frequency of Migraines 
Source SS df MS F p ηp2 
Between subjects       
    Treatment type 31.29 1.00 31.29 5.21 .027 .10 
Child age 8.47 1.00 8.47 1.41 .241 .03 
Child gender 0.51 1.00 0.51 0.09 .772 .05 
Socioeconomic status 15.23 1.00 15.23 2.53 .118 .051 
    Residuals 282.41 47.00 6.01 - - - 
Within subjects       
    Time 5.20 1.00 5.20 5.92 .019 .11 
Time x Treatment 0.24 1.00 0.24 0.28 .600 .01 
Time x Child Age 0.03 1.00 0.03 0.03 .866 .00 
Time x Child Gender 0.82 1.00 0.82 0.93 .340 .02 
Time x Socioeconomic 
Status 0.58 1.00 0.58 0.66 .422 .01 
Error (time) 41.26 47.00 0.88 - - - 
 
Table 5  
Means and Standard Deviations for Factor Level Combinations Involving Migraine 
Frequency 
  Frequency before Frequency after Row average 
Treatment M (SD) M (SD) M (SD) 
Medication only 3.64 (1.95) 2.11 (1.81) 2.88 (2.02) 
Biofeedback and medication 4.62 (2.08) 3.42 (1.64) 4.02 (1.95) 
Column average 4.10 (2.05) 2.71 (1.84) 3.40 (2.06) 
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Research Subquestion 2 
 The main effect for treatment type was significant, F(1, 47) = 6.71, p = .013, 
indicating significant differences in migraine intensity among the values of treatment. In 
other words, without taking into account the repeated measurements, differences occurred 
in migraine intensity between treatment types. On average, those in the medication only 
group had lower migraine intensity than those in the medication plus biofeedback group. 
Those in the medication only group had 1.31 units lower migraine intensity. Table 7 
presents full descriptive statistics by group and timepoint. The main effect for the within-
subjects factor (time) was not significant, F(1, 47) = 2.74, p = .105, indicating no 
significant differences in migraine intensity 1 month before and 1 month after treatment.  
 The interaction effect between the within-subjects factor and treatment type was 
not significant, F(1, 47) = 0.40, p = .528, indicating no significant differences in migraine 
intensity between treatment types and time points. In other words, medication plus 
biofeedback does not seem to be more effective than medication alone in reducing 
migraine intensity. The null hypothesis for Sub-Research Question 2 was not rejected. 
Table 6 presents the ANCOVA results. Table 7 presents means and standard deviations 
for each factor level combination and row and column averages. As the null hypotheses 
for both Sub-Research Question 1 and 2 could not be rejected, the null hypothesis for the 
Omnibus Research Question could not be rejected.   
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Table 6  
Results of Mixed Model ANCOVA Involving Intensity of Migraines 
Source SS df MS F p ηp2 
Between-Subjects       
    Treatment Type 14.45 1.00 14.45 2.42 .126 .05 
Child Age 1.82 1.00 1.82 0.31 .583 .01 
Child Gender 3.09 1.00 3.09 0.52 .475 .01 
Socioeconomic Status 40.00 1.00 40.00 6.71 .013 0.125 
    Residuals 280.136 47.00 5.96 - - - 
Within-Subjects       
    Time 3.55 1.00 3.55 2.74 .105 .06 
Time x Treatment 0.52 1.00 0.52 0.40 .528 .01 
Time x Child Age 4.46 1.00 4.46 3.44 .070 .07 
Time x Child Gender 1.98 1.00 1.98 1.53 .222 .03 
Time x Socioeconomic 
Status 0.41 1.00 0.41 0.31 .578 .01 
Error (Time) 60.95 47.00 1.30 - - - 
Table 7  
Means and Standard Deviations for Factor Level Combinations 
  Intensity Before Intensity After Row Average 
Treatment M (SD) M (SD) M (SD) 
Medication only 6.71 (1.98) 4.04 (2.27) 5.38 (2.50) 
Biofeedback and medication 7.83 (1.74) 5.54 (1.53) 6.69 (1.99) 





 The purpose of this quasi-experimental quantitative research was to determine if a 
difference in treatment perception was apparent between the parents of children who 
received biofeedback and medication or medication only for treatment of their chronic 
migraines. Of the 52 participants, most were female, had female children, and 
characterized themselves as middle class. Results indicated that although decreases 
occurred in reported migraine frequency and intensity in both the medication only and 
medication plus biofeedback groups, no statistically significant interaction occurred 
between the within-subjects factor of time and treatment type. This indicates that, for this 
sample, medication plus biofeedback treatment was not more effective at reducing the 
frequency and intensity of children’s migraines than medication only treatment. 
Biofeedback and medication treatment is not as effective at reducing the frequency and 
intensity of children’s migraine headaches as medication only. As such, the null 
hypothesis for the Omnibus Research Question was not rejected.  
 In Chapter 5 I will present further interpretations and implications of these 
findings. I will also detail the limitations and recommendations. Additionally, I will 





Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
Biofeedback is an alternative therapy for migraines that has demonstrated efficacy 
in the adult population (Guirguis-Blake, 2010). Biofeedback may also work for children 
(Eccleston et al., 2001; Hermann & Blanchard, 2002; Jindal et al., 2008). To date, no 
researchers have measured the effectiveness of biofeedback therapy in children using 
caregiver ratings to record the child’s pain level. Previous research focusing on 
perceptions of medical staff have shown that medical staff’s assessments are not always 
accurate concerning a child’s pain experience (Craig et al., 1996; Jylli & Olsson, 1995). 
The purpose of this quantitative, quasi-experimental study was to measure the 
effectiveness of biofeedback as a complementary therapy in child migraine patients as 
shown through surveys completed by caregivers. Although both medication only and 
biofeedback and medication groups showed improvement when compared through pre- 
and posttreatment phases, results of the parent ratings surveys indicated no significant 
difference between those children who were treated with biofeedback and medication and 
those who were treated with medication alone.  
 In this chapter, I provided additional discussion of the findings, including an 
interpretation in terms of extant literature and the theoretical framework. Subsequently, I 
outline the limitations of the study and offer recommendations to further the literature on 
the treatment of children with migraines. Finally, I conclude with the implications of the 
study and final conclusions.   
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Interpretation of Findings 
Omnibus Research Question 
The findings disconfirmed the hypothesis that those receiving biofeedback and 
medication treatment would experience less migraine frequency and intensity than those 
who received medication only. The overall findings of this study indicated that those who 
were in the medication plus biofeedback group had more migraines and more intensity 
than those in the medication only group; however, the differences between the two 
groups was not great. Both treatment groups displayed a decreased frequency and 
intensity of migraines at 1-month posttreatment. When comparing the results of the study 
to the existing literature, I expected a more apparent improvement in the group receiving 
biofeedback plus medication, and there was not. It is possible that those who were having 
more frequent and intense migraines are more difficult to treat than those who were 
treated by medication only. This theory is substantiated by the initially higher scores for 
both frequency and intensity for the biofeedback plus medication group in the 
pretreatment phase. It is also possible that those in the medication only group were 
influenced to some degree by placebo effect; in addition, those placed in the biofeedback 
plus medication group may have been those with more severe cases because those in the 
medication only group had lower overall migraine frequency. Biofeedback has been 
shown to be successful in treating both migraines with aura and those without aura 
(Vasudeva, Claggett, Tietjen & McGrady, 2003). Because of this finding I did not screen 
for presence or absence of this condition. 
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Demographic variables showed that more participants were female (i.e., female 
parents: n = 36, 69.23% and female child migraine sufferers: n = 31, 59.62%) as opposed 
to male (male parents: n = 16, 30.77% and male child migraine sufferers: n = 21, 
40.38%). The age of the adult participants ranged from 24 to 60 years old, with a median 
of 46.5 years old and a mode of 49 years old. Child migraine sufferer ages ranged from 1 
year of age to 17 years old, with a median of 13 years old and a mode of 17 years old. 
The mean age of all parent respondents was 43.5 years old and mean age for child 
migraine sufferers was 11.9 years old. The SES of most of the participants (51.9%, n = 
27) fell in the middle range of $42,000 to $ 125,000 with only 15% (n = 8) falling in the 
low range of below $42,000. There were 32.6% (n = 17) in the over $125,000 upper 
socioeconomic category. These demographics are comparable to the existing literature on 
the subject. 
Frequency of Migraines 
 Considering the findings of the study regarding frequency of migraines between 
treatment types, I found an improvement in lesser frequency of migraines in both 
treatment groups. However, I hypothesized that less migraine frequency would occur in 
the biofeedback group, and this did not occur. One possible mitigating factor for this may 
be attributed to the 1-month treatment period not providing an adequate amount of time 
for biofeedback skill acquisition. Lipchik (2001) suggested it may take many sessions to 
acquire biofeedback techniques in adults. This study had a lack of longitudinal data, and 
it is quite reasonable to expect children to take at least as long as adults to learn 
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biofeedback skills and probably longer. Therefore, there may not have been enough time 
to adequately assess the outcomes of the biofeedback in this sample. This may explain 
the similar rates of migraines in the two groups and lack of efficacy shown through the 
data for biofeedback at post-1 month of treatment. A lengthier period of time to acquire 
biofeedback skills may make a significant difference in the outcome.  
Intensity of Migraines 
Considering the findings regarding intensity between treatment types, I 
hypothesized that migraines would occur with less intensity following treatment with 
biofeedback and medication than with medication alone. This was not proven in this 
study. It is postulated that those in the biofeedback plus medication group had higher 
rates of symptoms; therefore, this group may have been more difficult to treat from the 
outset. It is important to remember that both groups did show improvement 1 month after 
treatment. The biofeedback group simply did not show more improvement than the 
medication only group as predicted. 
Theoretical Framework 
In this study, I initially focused on gate theory and its ability to interrupt pain 
impulses with the postulation that biofeedback may use that means to mitigate pain. This 
framework could be widened to include not only the interaction of biofeedback as an 
effective pain relief method but also the additional placebo effect of medications 
(Weimer, 2013). The marked difference between pain assessments of pretreatment and 
posttreatment migraine sufferers may suggest that children who receive treatment are 
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more likely to feel better than those who do not. Alternately, it could be that the 
medication alone is successfully treating the migraines. However, in many instances, 
medications are not immediately effective in stopping migraines or lessening their 
severity, especially in a brief time period (American Migraine Foundation, 2019). 
Because it typically takes a bit longer than 1 month to get positive results from migraine 
preventative medication, the medication group results may be because of a placebo effect 
as opposed to an actual improvement in symptoms. A longer period of study may provide 
more accurate results.  
Limitations of the Study 
The biggest limitation of the study was my short-term approach to child migraine 
pain treatment. A longitudinal study could follow participants for months or years far 
beyond the initial 1 month before treatment and 1 month after treatment. This approach 
may reveal different results. Specifically, because biofeedback skills are acquired over 
time, at only 1 month into treatment many children may not have developed the means 
with which to employ those skills (Lipchik, 2008).  
An additional potential limitation was that the results relied on parents’ ratings of 
their children’s pain. Although parents or caregivers may answer the ratings scales with 
the best of intentions, they may not be able to record all the improvements children may 
feel as treatment takes place. Therefore, relying on caregivers or parents may provide a 
more accurate pain assessment than that of a medical worker it could likely not be as 




This study relied on parents’ ratings of children’s pain. Having a reliable 
numerical rating scale for a parent or caregiver to contribute in migraine treatment may 
help the parent more accurately assess the pain and contribute directly to more effective 
management of the child’s pain overall. I recommend that a standardized instrument be 
developed to help future researchers more accurately assess interventions into children’s 
migraines. Future researchers should consider a longitudinal approach to data collection 
in biofeedback for child migraine. If a longer amount of time were devoted to 
posttreatment assessment, results may be more favorable for the reasons I expressed in 
the Limitations section. More time to acquire biofeedback skills could ultimately improve 
the chances for long-term positive effects from the therapy. Use of gate control theory to 
lessen migraine pain may be more readily apparent in those who are able to spend more 
time learning to employ biofeedback successfully (Lipchik, 2008). One month of 
treatment is simply not enough time; adults typically require several months to master 
this skill (Lipchik, 2008). 
Implications 
Parent feedback can be helpful in overall child pain assessment. As stated in 
Chapter 2, children may not always be able to communicate effectively in medical 
settings. A simple numerical rating scale can provide valuable information on how 
children are experiencing their pain, and getting parental input provides medical 
personnel with valuable insight from those familiar with the child’s characteristic 
63 
 
behaviors. Theoretical implications suggest that gate theory and placebo effect were at 
work in this study. Although participants may have experienced the effects of gate theory 
with biofeedback controlling pain impulses to improve migraine, the placebo effect may 
have been at work in helping those who received medication feel better even before the 
medications could properly take effect. Empirical implications gleaned from this study 
suggest that parents placed higher significance in medication as a treatment for children’s 
migraines. This may have affected the children’s response to the medications as well as 
those of their parents, which were reflected in turn by the parent rating of the medication 
only group being higher than that of the medication and biofeedback group (see Faria et 
al., 2017). Data reflected improvement after a 1-month medication trial. Although some 
medications may take effect quickly, others may take much longer than 1 month to show 
positive effects. This calls for further investigation. Knowing specifically which 
medications were prescribed to participants would be helpful. For medications that do not 
take effect quickly but still reflect improvement, the placebo effect may be considered 
(Faria et al, 2017). Theory reflecting the placebo effect may contribute to the differences 
in the study results. Finding effective treatments for children with migraines frees them to 
participate in daily life and become productive members of society.  
Positive social change is immediately apparent when a sick child with migraine 
becomes well. Children who experience less migraine frequency and intensity can go to 
school and learn. A parent may go to work without the worry of their child’s health 
distracting them. This makes for a better workplace and, in turn, a stronger economy. 
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Children’s health and wellness is an important topic that affects people at both the 
individual and global levels. Keeping children healthy and productive ensures both 
children and parents have a bright future. 
Conclusions 
In this study, parents with children suffering from migraine headaches rated their 
child’s pain in frequency and intensity both 1 month before and 1 month after treatment 
with medication and medication and biofeedback. I found that parents who treated their 
children with medication and biofeedback did not report better relief for their children at 
1 month of treatment than those who received only medication to treat their migraines. 
For future studies, a longer trial period for children to practice biofeedback skills is 
recommended. As biofeedback skills improve with practice, long-term improvement of 
migraine symptoms is hypothesized. Finding the answers to cure child migraine often are 
elusive. Medications are not always effective or a quick fix and may have additional 
unwanted side effects. An open mind to alternative or complementary treatments may 
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Appendix A: Demographic Survey 
 
1).How is your child treated for migraines? 
 Medication only or Biofeedback and medication (pick one) 
 
2).What is your age? What is your child’s age? 
 
3).  What is your gender?  Gender of your child? 
 
4).   How would you describe you and child’s Socioeconomic Status : 
      Lower/ Middle or Upper class? 
 
5.    How many migraines did your child experience in 1 month BEFORE treatment? 
 
6).    How many Migraines did your child experience in 1 month AFTER treatment? 









Appendix B: Permission to use INRS Instrument 
 
From: "Curley, Martha A.Q."  
Date: August 1, 2017 at 8:33:57 PM EDT 
To: Andrea Weber  
Subject: Re: Permission for use letter requested: INRS 
OK --- I’m happy to have you use the INRS for your project.  Best wishes for 
continued success.  
  
Martha A.Q. Curley, RN, PhD, FAAN 
